Yeah, well, trying to have a sensible debate in the Outside would need an analogy like that 
I got the questionnaire & saliva sample kit for part 2 of this study in the mail today.![]()
I got mine today, too.
I found this commentary on the Etter piece by Foulds and Veldheer. Commentary on Etter & Bullen (2011): Could E-cigs become the ultimate nicotine maintenance device? - FOULDS - 2011 - Addiction - Wiley Online Library
Very nice to see Dr. Foulds write such a positive article and not end it with, "Until more is known, smokers looking to quit should use products deemed safe and effective by the FDA."
@Spazmelda: yet another sensible article. Could common sense go viral?
I found this commentary on the Etter piece by Foulds and Veldheer. Commentary on Etter & Bullen (2011): Could E-cigs become the ultimate nicotine maintenance device? - FOULDS - 2011 - Addiction - Wiley Online Library
As you say, there are no NRTs or other quit-smoking drugs that are both "safe and effective". They are either virtually useless, or ineffective and also dangerous. The one with the highest success rate, Chantix, is believed to have caused 62,500 heart attacks in the USA last year. I'm not sure how that qualifies as 'safe', but perhaps they have a different definition in the FDA.
I haven't come across a 20-month success figure for Chantix but it is supposed to be about 8%. Maybe someone knows of a reference?
My personal opinion is that a doctor who prescribes it, knowing how dangerous it is, is getting very close to negligence. With a better than one in thirty chance of ruining that person's life (and that of their families), and knowing the scale of the problem - and since there are far better options available - I fail to see how there can be any other interpretation.
Ashtray Blog comments on the study:
Ecig research floundering to understand what vapers already know
I find it interesting that they want to reduce nicotine level in cigarettes. So let's think this through... We cut nicotine (an addictive but fairly safe compound) by half. Smokers start smoking twice as much to compensate. More cigarette sales, more cancer, more COPD, more die. Yep, that sounds like the right answer, let's go with that!
Can cigarette size and nicotine co... [Psychopharmacology (Berl). 1978] - PubMed - NCBIThe stimuli controlling the rate at which people smoke cigarettes have not been clearly defined. On the hypothesis that smoking is basically nicotine-seeking behavior, nicotine available to the subject was experimentally manipulated through controlling cigarette size and nicotine content. In Experiment I, subjects given their won cigarettes in whole, half, quarter, and eighth lengths, increased the number of cigarettes smoked and number of puffs to compensate for reductions in size. Satisfaction was directly related to cigarette length. In Experiment II, subjects given special cigarettes delivering 0.2 or 2.0 mg nicotine/cigarette smoked significantly more of the low than of the high nicotine cigarettes and took significantly more puffs. As in Experiment I, significantly more quarter length than full length cigarettes were smoked, but total number of puffs did not differ. These results support the hypothesis that nicotine controls smoking behavior.
Relation of nicotine yield of cigarettes to blood n... [Br Med J. 1980] - PubMed - NCBIThese results suggest that the assumed health advantage of switching to lower-tar and lower-nicotine cigarettes may be largely offset by the tendency of smokers to compensate by increasing inhalation.
Analyses of the urinary nicotine metabolites showed that smokers allocated to each of the three study cigarettes adjusted their smoking so that throughout the trial their nicotine inhalation differed little from their pretrial intakes when they were smoking their own cigarettes. As a result of the altered patterns of smoking to compensate for the reduced nicotine yields of the three study cigarettes, the tar intake of those allocated to smoke the middle tar, middle nicotine cigarettes remained essentially unchanged, while those allocated to smoke the low tar, low nicotine and low tar, middle nicotine cigarettes had calculated reductions in tar intakes of about 14% and 18%, respectively.
CONCLUSIONS: Due to the phenomenon of compensation, tar intake can only be reduced substantially by using a cigarette with a markedly lower tar/nicotine ratio.
Smoking history, cigarette yield and ... [Eur J Respir Dis Suppl. 1986] - PubMed - NCBIThese data suggest that smoking history, nicotine yield of the cigarette and smoking behavior are all determinants of smoke exposure. Further, although smokers of low-yield cigarettes appear to compensate by puffing larger volumes per cigarette, this compensation appears to be inadequate to attain an equivalent smoke exposure.
Influence of smoking fewer cigarettes on exposu... [N Engl J Med. 1986] - PubMed - NCBIWe measured the intake of tar (estimated as mutagenic activity of the urine), nicotine, and carbon monoxide during short-term cigarette restriction. With a reduction from an average of 37 cigarettes to an average of 5 cigarettes per day, the intake of tobacco toxins per cigarette increased roughly threefold and daily exposure to tar and carbon monoxide declined only 50 percent. We conclude that smoking fewer cigarettes may reduce exposure to toxins and related adverse health consequences. However, consistent with a tendency to maintain intake of nicotine, the magnitude of the benefit is much less than expected. Whether "oversmoking" persists during long-term restriction of cigarettes requires further investigation.
Smoking behaviour and compensation... [Psychopharmacology (Berl). 1999] - PubMed - NCBICONCLUSIONS: The available data suggest that smokers partially compensate for a different smoke yield. While the factors and their interaction responsible for compensational smoking are not fully understood, there are data suggesting that a subgroup of smokers may partially compensate for nicotine
Reduced nicotine content cigarettes: effects on to... [Addiction. 2010] - PubMed - NCBIAbstract
AIMS:
To examine the effects of reduced nicotine cigarettes on smoking behavior, toxicant exposure, dependence and abstinence.
DESIGN:
Randomized, parallel arm, semi-blinded study. Setting University of Minnesota Tobacco Use Research Center.
INTERVENTIONS:
Six weeks of: (i) 0.05 mg nicotine yield cigarettes; (ii) 0.3 mg nicotine yield cigarettes; or (iii) 4 mg nicotine lozenge; 6 weeks of follow-up. Measurements Compensatory smoking behavior, biomarkers of exposure, tobacco dependence, tobacco withdrawal and abstinence rate.
FINDINGS:
Unlike the 0.3 mg cigarettes, 0.05 mg cigarettes were not associated with compensatory smoking behaviors. Furthermore, the 0.05 mg cigarettes and nicotine lozenge were associated with reduced carcinogen exposure, nicotine dependence and product withdrawal scores. The 0.05 mg cigarette was associated with greater relief of withdrawal from usual brand cigarettes than the nicotine lozenge. The 0.05 mg cigarette led to a significantly higher rate of cessation than the 0.3 mg cigarette and a similar rate as nicotine lozenge.
CONCLUSION:
The 0.05 mg nicotine yield cigarettes may be a tobacco product that can facilitate cessation; however, future research is clearly needed to support these preliminary findings.